vimarsana.com
Home
Live Updates
Dr Chari on Findings From the MonumenTAL-1 Trial in Relapsed/Refractory Multiple Myeloma : comparemela.com
Dr Chari on Findings From the MonumenTAL-1 Trial in Relapsed/Refractory Multiple Myeloma
Ajai Chari, MD, discusses the efficacy of treating patients with less frequent or lower intensity dosing of talquetamab in patients with relapsed/refractory multiple myeloma, as evaluated in the phase 1/2 MonumenTAL-1 study.
Related Keywords
California ,
United States ,
San Francisco ,
,
Myeloma Program ,
University Of California ,
Helen Diller Family Comprehensive Cancer Center ,
Findings From ,
Refractory Multiple ,
Multiple Myeloma Program ,
Diller Family Comprehensive Cancer Center ,
Ash Annual Meeting And Exposition ,
Onclive Tv ,
Multiple Myeloma ,
comparemela.com © 2020. All Rights Reserved.